Franco Orsi

Totally implantable central venous access ports for long-term chemotherapy A prospective study analyzing complications and costs of 333 devices with a minimum follow-up of 180 days

Roberto Biffi, Filippo de Braud, Franco Orsi et al. · Annals of Oncology · 1998 · 285 citations

Implantable Device, Surgical Oncology, Oncology +10

Best choice of central venous insertion site for the prevention of catheter-related complications in adult patients who need cancer therapy: a randomized trial

Roberto Biffi, Franco Orsi, S. Pozzi et al. · Annals of Oncology · 2009 · 234 citations · Full text

Surgical Oncology, Medicine, Cancer Management +10

Consensus Guidelines for the Definition of Time-to-Event End Points in Image-guided Tumor Ablation: Results of the SIO and DATECAN Initiative

Robbert S. Puijk, Muneeb Ahmed, Andreas Adam et al. · Radiology · 2021 · 152 citations · Full text

Biokinetics and dosimetry in patients administered with 111 In-DOTA-Tyr 3 -octreotide: implications for internal radiotherapy with 90 Y-DOTATOC

Marta Cremonesi, Mahila Ferrari, Stefania Zoboli et al. · European Journal of Nuclear Medicine and Molecular Imaging · 1999 · 150 citations

In-dota-tyr 3, Internal Radiotherapy, Radiation Therapy +11

Long-term, totally implantable central venous access ports connected to a Groshong atheter for chemotherapy of solid tumours: Experience from 178 cases using a single type of device

Roberto Biffi, F Corrado, Filippo de Braud et al. · European Journal of Cancer · 1997 · 115 citations

Surgical Oncology, Oncology, Engineering +10